HIV/AIDS Headlines

One-Time Routine HIV Screening at Age 25 Optimal With No Risk Factors

One-Time Routine HIV Screening at Age 25 Optimal With No Risk Factors

Using adult quality-of-life weights for adolescents and young adults increased the incremental cost-effectiveness ratios of screen at 25 compared to screen at age 30 to $115,900/quality-adjusted life-year.

Vagus Nerve Stimulation May Improve HIV-Associated Depression

Vagus Nerve Stimulation May Improve HIV-Associated Depression

Transcutaneous vagus nerve stimulation could provide a safe alternative treatment in HIV-depression by targeting both depression and other comorbidities that can burden people living with HIV.

Psychosocial Risk Factors in Adolescence Linked to HIV Vulnerability in Adulthood

Psychosocial Risk Factors in Adolescence Linked to HIV Vulnerability in Adulthood

High-frequency psychosocial risk factors during adolescence have a lasting effect on the likelihood of engaging in HIV risk behaviors in adulthood.

Primary Care: Next Frontier in Managing HIV Care

Primary Care: Next Frontier in Managing HIV Care

Primary care providers will play an important role in preventing the next wave of HIV infections.

Value of Confirmatory Testing of Early Infant Diagnosis for HIV

Value of Confirmatory Testing of Early Infant Diagnosis for HIV

Confirmatory testing is valuable and cost-effective for assessing HIV in infants considering false-positive rates of more than 10% when using nucleic acid amplification testing.

More Evidence That Early Diagnosis of HIV and Early ART Are Beneficial

More Evidence That Early Diagnosis of HIV and Early ART Are Beneficial

Since early ART limits HIV reservoir size and preserves central memory CD4 cells, patients treated from primary HIV infection with low HIV-DNA levels might be good candidates for future HIV cure strategies.

Low Adherence to Guidelines for Cardiovascular Care in HIV

Low Adherence to Guidelines for Cardiovascular Care in HIV

A new study sought to qualify the adherence to evidence-based cardiovascular care guidelines for patients living with HIV.

Can We Prevent HIV and STIs Through School Programs?

Can We Prevent HIV and STIs Through School Programs?

Although a positive impact on behavior change has been reported following the implementation of curriculum-based programs, there is a lack of clear evidence that school-based educational interventions directly prevent HIV/STIs.

Breastfeeding Mediates Pneumonia Outcomes in HIV-Exposed Children

Breastfeeding Mediates Pneumonia Outcomes in HIV-Exposed Children

Investigators evaluated pneumonia outcomes and HIV exposure with birth weight status, malnutrition, breast feeding, in utero exposure to combination antiretroviral therapy, or the severity of pneumonia.

How HIV Affects Cervical Cancer Risk and Outcomes

How HIV Affects Cervical Cancer Risk and Outcomes

Women with HIV have an increased risk for persistent HPV infection, which frequently progresses to cervical cancer, and they should be warned of their increased risk for HPV and cervical cancer and, when appropriate, advised to undergo HPV vaccination.

Acquired HIV Drug Resistance Unlikely With Immediate ART Initiation

Acquired HIV Drug Resistance Unlikely With Immediate ART Initiation

In high-income countries, the need for second-line treatments due to the development of acquired drug resistance will increase only slightly under the new ART initiation guidelines.

HIV Neurocognitive Performance Not Associated With Recent Alcohol Intake

HIV Neurocognitive Performance Not Associated With Recent Alcohol Intake

The only areas in which neurocognitive performance in the sample was significantly associated with alcohol use were visual memory/learning and attention.

Higher CKD Risk in HIV With Combination Tenofovir, Boosted Protease Inhibitor

Higher CKD Risk in HIV With Combination Tenofovir, Boosted Protease Inhibitor

In patients living with HIV receiving TDF with a ritonavir-boosted protease inhibitor, the risk of CKD may be increased.

Pausing ART to Identify Biomarkers for HIV RNA Rebound: Safety and Ethical Considerations

Pausing ART to Identify Biomarkers for HIV RNA Rebound: Safety and Ethical Considerations

Dr Gianella Weibel talks with Dr Li and Dr Dubé, investigators of a new study from the AIDS Clinical Trials Group, which uses an intensively monitored antiretroviral pause to identify changes in HIV reservoirs after anti-HIV medications are stopped.

CDC Reports HIV Diagnoses Occur Sooner After Infection

CDC Reports HIV Diagnoses Occur Sooner After Infection

The CDC stated that HIV is being diagnosed sooner after infection than previously reported.

SIGN UP FOR FREE E-NEWSLETTERS